A team of researchers made a breakthrough in the search for treatments for multiple sclerosis (MS) and other ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

Ancient viral DNA embedded in the human genome has been linked to the genetic risks of certain neurodegenerative diseases, ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

The FDA grants breakthrough therapy designation to expedite ... and there remains a significant unmet need for MS treatment. Year to date, shares of Sanofi have declined 5.5% against the industry ...

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a promising breakthrough in the <a ...

Steven Petratos and his team at Melbourne's Monash University are one step closer to developing a potential treatment for ... could potentially treat Multiple Sclerosis (MS) and even reverse ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

and there remains a significant unmet need for MS treatment. Year to date, shares of Sanofi have declined 5.5% against the industry’s increase of 7.4%. The FDA’s Breakthrough Therapy ...